Sinusin
FDA Label NDC 50114-3250

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Heel Inc for the product Sinusin (NDC 50114-3250). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding keep out of reach of children, indications and usage, warnings, dosage and administration, active ingredients, inactive ingredients, purpose, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Keep Out Of Reach Of Children

Keep this and all medications out of the reach of children.

Indications And Usage

For the temporary relief of:
  • Nasal Congestion
  • Rhinitis and Sinusitis
  • Cold and Flu Nasal Symptoms

Warnings

If symptoms persist or worsen, a physician should be consulted. As with any drug, if you are pregnant or nursing a baby, seek the advise of a health care professional before using this product.

Dosage And Administration

Adults and Children above 11 years: 10 drops orally 3 times daily, or as directed by a physician. Consult a physician for use in children under 12 years of age.

Active Ingredients

Each 50ml contains: Pulsatilla 2X, Euphorbium officinarum 6X, Luffa operculata 6X, Mercurius iodatus ruber 6X, Influenzinum 8X, Argentum nitricum 10X, Hepar sulphuris calcareum 10X, Sinusitisinum 13X 0.5 ml each.

Inactive Ingredients

Ethanol, Purified Water USP

Purpose

Nasal Congestion, Rhinitis and Sinusitis, Cold and Flu Nasal Symptoms

* Please review the disclaimer below.